Hiroaki Taniguchi
About
In The Last Decade
Hiroaki Taniguchi
108 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.2k
- Oncology 635
- Cancer Research 482
- Immunology 469
- Pulmonary and Respiratory Medicine 454
Countries citing papers authored by Hiroaki Taniguchi
This map shows the geographic impact of Hiroaki Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Taniguchi more than expected).
Fields of papers citing papers by Hiroaki Taniguchi
This network shows the impact of papers produced by Hiroaki Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Taniguchi. The network helps show where Hiroaki Taniguchi may publish in the future.
Co-authorship network of co-authors of Hiroaki Taniguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Taniguchi. A scholar is included among the top collaborators of Hiroaki Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Taniguchi. Hiroaki Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 37 | |
| 6 | 42 | |
| 7 | 12 | |
| 8 | 12 | |
| 9 | 53 | |
| 10 | 1 | |
| 11 | 146 | |
| 12 | 15 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 46 | |
| 16 | OJ-478 Plasma Matrix Metalloprotease (MMP)-8 Levels Are Associated With the Presence and Severity of Coronary Artery Disease (CAD)(Angina Pectoris, Clinical 3 (IHD) : OJ58)(Oral Presentation (Japanese)) | 2 |
| 17 | 50 | |
| 18 | 58 | |
| 19 | 123 | |
| 20 | 49 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.